Abstract
Purpose
The study aimed to investigate whether repeat number in the androgen receptor (AR) gene has any contribution to phenotypes of the disease of androgen excess (polycystic ovary syndrome (PCOS), idiopathic hyperandrogenemia (IHA) and idiopathic hirsutism (IH) in a cohort of Turkish women.
Methods
Three hundred and fifty-four voluntary premenopausal women (172 healthy controls and 182 patients with androgen excess disorders and idiopathic hirsutism) 18–45 years of age seen at an outpatient endocrine clinic at Erciyes University Hospital between January 2013 and December 2014 were included. All volunteers have undergone physical examination and biochemical evaluation. The polymorphic (CAG)n repeat of the human AR was determined by fragment analyses.
Results
Detailed clinical analyses of the patients ended up with 137 PCOS, 24 IHA, and 21 IH. Pairwise comparisons revealed the CAG repeat number differences between the PCOS and controls (p = 0.005) and IH and controls (p = 0.020). Women with CAG repeat length ≤ 17 had a significantly increased twofold risk for PCOS than those women with > 17 CAG repeats OR: 2.0 (95% CI 1.2–3.3, p = 0.005). Women with CAG repeat length ≤ 17 had a significantly increased threefold risk for IH than those women with > 17 CAG repeats OR: 2.9 (95% CI 1.2–7.3, p = 0.020). When correlation analysis was performed, a weak negative correlation was detected between the short allele and FGS score (r = − 0.131, p = 0.013) and a positive relationship between total testosterone and longer allele in the IHA group (r = 0.425, p = 0.039). Median repeat length of the shorter allele between oligomenorrhea and woman with normal menstrual cycle was found to be statistically significant (p = 0.017).
Conclusion
This study indicated that the risk of PCOS and IH is associated with the inheritance of ARs with shorter CAG repeats.
Similar content being viewed by others
References
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF (2009) The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91 (2):456–488. https://doi.org/10.1016/j.fertnstert.2008.06.035
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7 (4):219–231. https://doi.org/10.1038/nrendo.2010.217
Barber TM, Franks S (2013) Genetics of polycystic ovary syndrome. Polycyst Ovary Syndr Novel Insight Causes Ther 40:28–39
Panda PK, Rane R, Ravichandran R, Singh S, Panchal H (2016) Genetics of PCOS: a systematic bioinformatics approach to unveil the proteins responsible for PCOS. Genom Data 8:52–60. https://doi.org/10.1016/j.gdata.2016.03.008
Azziz R, Carmina E, Sawaya ME (2000) Idiopathic hirsutism 1. Endocr Rev 21 (4):347–362
Escobar-Morreale HF, Serrano-Gotarredona J, Garcia-Robles R, Sancho J, Varela C (1997) Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 46 (8):902–907
Escobar-Morreale H, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne C, Witchel S (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 18 (2):146–170
Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F (2004) A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diabetes 112 (9):504–509. https://doi.org/10.1055/s-2004-821307
Carmina E (2006) The spectrum of androgen excess disorders. Fertil Steril 85 (6):1582–1585. https://doi.org/10.1016/j.fertnstert.2006.02.069
Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HF (1989) Androgen receptor locus on the human X-chromosome—regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 44 (2):264–269
Carson-Jurica MA, Schrader WT, O'Malley BW (1990) Steroid receptor family: structure and functions. Endocr Rev 11 (2):201–220. https://doi.org/10.1210/edrv-11-2-201
Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22 (15):3181–3186
La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (6330):77–79. https://doi.org/10.1038/352077a0
Zhang T, Liang W, Fang M, Yu J, Ni Y, Li Z (2013) Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis. Gene 524 (2):161–167. https://doi.org/10.1016/j.gene.2013.04.040
Schuring AN, Welp A, Gromoll J, Zitzmann M, Sonntag B, Nieschlag E, Greb RR, Kiesel L (2012) Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS). Exp Clin Endocrinol Diabetes 120 (2):73–79. https://doi.org/10.1055/s-0031-1291343
Calvo RM, Asuncion M, Sancho J, San Millan JL, Escobar-Morreale HF (2000) The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. J Clin Endocrinol Metab 85 (4):1735–1740. https://doi.org/10.1210/jcem.85.4.6561
Wang R, Goodarzi MO, Xiong T, Wang D, Azziz R, Zhang H (2012) Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod 18 (10):498–509. https://doi.org/10.1093/molehr/gas024
Legro RS, Shahbahrami B, Lobo RA, Kovacs BW (1994) Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgenic characteristics. Obstet Gynecol 83 (5 Pt 1):701–706
Skrgatic L, Baldani DP, Cerne JZ, Ferk P, Gersak K (2012) CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels. J Steroid Biochem Mol Biol 128 (3–5):107–112. https://doi.org/10.1016/j.jsbmb.2011.11.006
Ferriman D, Gallwey J (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metabol 21 (11):1440–1447
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical E, American College of E, Androgen E, Society P (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome-Part 1. Endocr Pract 21 (11):1291–1300. https://doi.org/10.4158/EP15748.DSC
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical E, American College of E, Androgen E, Society P (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome—Part 2. Endocr Pract 21 (12):1415–1426. https://doi.org/10.4158/EP15748.DSCPT2
Escobar-Morreale HF, Serrano-Gotarredona J, Garcia-Robles R, Sancho J, Varela C (1997) Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metab Clin Exp 46 (8):902–907
Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (1):57–63
Naiki Y, Kawamoto T, Mitsuuchi Y, Miyahara K, Toda K, Orii T, Imura H, Shizuta Y (1993) A nonsense mutation (TGG [Trp116]–%3eTAG [Stop]) in CYP11B1 causes steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metabol 77 (6):1677–1682. https://doi.org/10.1210/jcem.77.6.7903314
Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metabol 78 (5):1145–1152. https://doi.org/10.1210/jcem.78.5.8175971
Chang YT, Kappy MS, Iwamoto K, Wang J, Yang X, Pang S (1993) Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Pediatr Res 34 (5):698–700. https://doi.org/10.1203/00006450-199311000-00026
Araujo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes JA, Billerbeck AE, Bachega TA (2007) Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metabol 92 (10):4028–4034. https://doi.org/10.1210/jc.2006-2163
Bharaj BS, Vassilikos EJ, Diamandis EP (1999) Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis. Clin Biochem 32 (5):327–332
Shah NA, Antoine HJ, Pall M, Taylor KD, Azziz R, Goodarzi MO (2008) Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metabol 93 (5):1939–1945. https://doi.org/10.1210/jc.2008-0038
Ferk P, Perme MP, Teran N, Gersak K (2008) Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome. Fertil Steril 90 (3):860–863. https://doi.org/10.1016/j.fertnstert.2007.07.1291
Laisk T, Haller-Kikkatalo K, Laanpere M, Jakovlev U, Peters M, Karro H, Salumets A (2010) Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels. Acta Obstet Gynecol Scand 89 (12):1557–1563. https://doi.org/10.3109/00016349.2010.526182
Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A (2008) The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Hum Reprod 23 (3):693–698. https://doi.org/10.1093/humrep/dem382
Xia Y, Che Y, Zhang X, Zhang C, Cao Y, Wang W, Xu P, Wu X, Yi L, Gao Q, Wang Y (2012) Polymorphic CAG repeat in the androgen receptor gene in polycystic ovary syndrome patients. Mol Med Rep 5 (5):1330–1334. https://doi.org/10.3892/mmr.2012.789
Ibanez L, Ong KK, Mongan N, Jaaskelainen J, Marcos MV, Hughes IA, De Zegher F, Dunger DB (2003) Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metabol 88 (7):3333–3338. https://doi.org/10.1210/jc.2002-021791
Hickey T, Chandy A, Norman RJ (2002) The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metabol 87 (1):161–165. https://doi.org/10.1210/jcem.87.1.8137
Rajender S, Carlus SJ, Bansal SK, Negi MP, Sadasivam N, Sadasivam MN, Thangaraj K (2013) Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS). PLoS ONE 8 (10):e75709. https://doi.org/10.1371/journal.pone.0075709
Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY (2008) Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril 90 (6):2318–2323. https://doi.org/10.1016/j.fertnstert.2007.10.030
Liu Q, Hong J, Cui B, Zhang Y, Gu W, Chi Z, Su Y, Ning G (2008) Androgen receptor gene CAG (n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome. Endocrine 33 (2):165–170. https://doi.org/10.1007/s12020-008-9069-7
Dasgupta S, Sirisha PV, Neelaveni K, Anuradha K, Reddy AG, Thangaraj K, Reddy BM (2010) Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with polycystic ovary syndrome. PLoS ONE 5 (8):e12401. https://doi.org/10.1371/journal.pone.0012401
Jaaskelainen J, Korhonen S, Voutilainen R, Hippelainen M, Heinonen S (2005) Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. Fertil Steril 83 (6):1724–1728. https://doi.org/10.1016/j.fertnstert.2004.11.080
Nenonen H, Bjork C, Skjaerpe PA, Giwercman A, Rylander L, Svartberg J, Giwercman YL (2010) CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol Hum Reprod 16 (3):153–157. https://doi.org/10.1093/molehr/gap097
Sawaya ME, Shalita AR (1998) Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 3 (1):9–15. https://doi.org/10.1177/120347549800300103
Weintrob N, Eyal O, Slakman M, Becker AS, Israeli G, Kalter-Leibovici O, Ben-Shachar S (2018) The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities. PLoS ONE. https://doi.org/10.1371/journal.pone.0195046
Brum IS, Spritzer PM, Paris F, Maturana MA, Audran F, Sultan C (2005) Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women. J Soc Gynecol Invest 12 (2):135–141. https://doi.org/10.1016/j.jsgi.2004.11.003
Mifsud A, Ramirez S, Yong EL (2000) Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metabol 85 (9):3484–3488. https://doi.org/10.1210/jcem.85.9.6832
Yamazaki M, Sato A, Toyoshima KE, Kojima Y, Okada T, Ishii Y, Kurata S, Yoshizato K, Tsuboi R (2011) Polymorphic CAG repeat numbers in the androgen receptor gene of female pattern hair loss patients. J Dermatol 38 (7):680–684. https://doi.org/10.1111/j.1346-8138.2010.01060.x
Tong D, Deng J, Sun H, Chen L, Wu X (2010) The relationship between CAG repeat length polymorphism and infertility in Southern Chinese Han women. J Endocrinol Invest 33 (8):559–563. https://doi.org/10.1007/BF03346648
Wang Q, Udayakumar TS, Vasaitis TS, Brodie AM, Fondell JD (2004) Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells. J Biol Chem 279 (17):17319–17328. https://doi.org/10.1074/jbc.M400970200
Lyon MF (1972) X-chromosome inactivation and developmental patterns in mammals. Biol Rev Camb Philos Soc 47 (1):1–35
Sharp A, Robinson D, Jacobs P (2000) Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 107 (4):343–349. https://doi.org/10.1007/s004390000382
Liu PY, Death AK, Handelsman DJ (2003) Androgens and cardiovascular disease. Endocr Rev 24 (3):313–340. https://doi.org/10.1210/er.2003-0005
Rytinki MM, Kaikkonen S, Sutinen P, Palvimo JJ (2011) Analysis of androgen receptor SUMOylation. Methods Mol Biol 776:183–197. https://doi.org/10.1007/978-1-61779-243-4_12
Funding
This work was supported by the Scientific Research Projects Coordination Unit of Erciyes University. Grand Number: TDK-2014–5099.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest relevant to the subject matter or materials included in this work.
Ethical approval
The study was approved by the Ethics Committee of Medical School at Erciyes University. All procedures performed in studies involving human participants and/or animals were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Polat, S., Karaburgu, S., Unluhizarci, K. et al. The role of androgen receptor CAG repeat polymorphism in androgen excess disorder and idiopathic hirsutism. J Endocrinol Invest 43, 1271–1281 (2020). https://doi.org/10.1007/s40618-020-01215-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01215-7